What is the treatment for hyperkalemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hyperkalemia

The treatment of hyperkalemia requires a stepwise approach consisting of cardiac membrane stabilization, intracellular potassium shifting, and total body potassium reduction, with immediate interventions for severe cases and longer-term management for chronic hyperkalemia. 1

Immediate Treatment for Severe Hyperkalemia

Step 1: Cardiac Membrane Stabilization

  • Calcium Gluconate 10%: 15-30 mL IV (10% solution) over 5-10 minutes
    • Onset: 1-3 minutes
    • Duration: 30-60 minutes
    • Purpose: Protects the heart from arrhythmias but does not lower potassium levels
    • Note: For cardiac arrest, calcium chloride is preferred 1, 2

Step 2: Intracellular Potassium Shifting

  1. Insulin with Glucose:

    • 10 units regular insulin IV with 50 mL of 25% dextrose
    • Onset: 15-30 minutes
    • Duration: 1-2 hours
    • Most reliable agent for promoting transcellular shift 1, 3
  2. Beta-agonists:

    • 10-20 mg nebulized over 15 minutes
    • Onset: 15-30 minutes
    • Duration: 2-4 hours
    • Can be used alone or to augment insulin's effect 1, 4
  3. Sodium Bicarbonate:

    • 50 mEq IV over 5 minutes
    • Only recommended if metabolic acidosis is present
    • Limited efficacy for shifting potassium alone 1, 3

Step 3: Potassium Removal from Body

  1. Hemodialysis:

    • Most efficient and reliable method for potassium removal
    • Indicated for severe, refractory hyperkalemia or in renal failure 1, 5
  2. Loop Diuretics:

    • IV furosemide if renal function permits
    • Promotes urinary potassium excretion 1, 4
  3. Potassium Binders:

    • Not for emergency treatment due to delayed onset 6, 7
    • Options include:
      • Patiromer (Veltassa): 8.4g once daily, onset 7 hours
      • Sodium zirconium cyclosilicate (Lokelma): 5-10g once daily, onset 1 hour
      • Sodium polystyrene sulfonate: 15-30g 1-4 times daily, variable onset 1

Monitoring During Treatment

  • Continuous cardiac monitoring for moderate to severe hyperkalemia
  • Serial ECGs to monitor for improvement of changes
  • Regular serum potassium measurements to avoid overcorrection 1

ECG Changes to Monitor

Potassium Level ECG Changes
5.5-6.5 mmol/L Peaked/tented T waves (early sign)
6.5-7.5 mmol/L Prolonged PR interval, flattened P waves
6.5-8.0 mmol/L Widened QRS, deep S waves
>10 mmol/L Sinusoidal pattern, VF, asystole, or PEA

Long-term Management

  1. Eliminate Reversible Causes:

    • Review and adjust medications that can cause hyperkalemia
    • Dietary potassium restriction (<40 mg/kg/day) 1, 5
  2. Dietary Modifications:

    • Avoid high-potassium foods: processed foods, bananas, oranges, potatoes, tomatoes, legumes, yogurt, chocolate 1
    • Sodium restriction (<2g/day)
    • Regular physical activity (150 min/week)
    • Weight reduction if overweight/obese 1
  3. Chronic Potassium Binder Therapy:

    • For recurrent or persistent hyperkalemia, especially in CKD
    • Patiromer preferred over sodium polystyrene sulfonate for chronic use due to fewer GI side effects 1, 4
  4. Nephrology Referral:

    • Essential for CKD stage 4 (eGFR <30 mL/min/1.73 m²)
    • Early involvement improves outcomes 1

Important Caveats and Pitfalls

  • Potassium binders (Lokelma, sodium polystyrene sulfonate) should NOT be used for emergency treatment of life-threatening hyperkalemia due to delayed onset 6, 7
  • Calcium gluconate is primarily effective for main rhythm disorders due to hyperkalemia but has limited effect on non-rhythm ECG disorders 2
  • Bicarbonate is less efficacious than previously thought and should only be used if metabolic acidosis is present 3
  • Physicians frequently fail to use effective treatments appropriately - follow the stepwise approach 3
  • Regular insulin is traditionally used, but some experts now recommend synthetic short-acting insulins 4

References

Guideline

Hyperkalemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The effect of calcium gluconate in the treatment of hyperkalemia.

Turkish journal of emergency medicine, 2022

Research

Hyperkalemia: treatment options.

Seminars in nephrology, 1998

Research

Controversies in Management of Hyperkalemia.

The Journal of emergency medicine, 2018

Research

Treatment and pathogenesis of acute hyperkalemia.

Journal of community hospital internal medicine perspectives, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.